Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer Patients

NCT05457075 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.

NCT NCT05457075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer Patients
Lead sponsor
Istanbul Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
February 15, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer